-
Merck's oral selective P2X3 receptor antagonist gefapixant enters review in the U.S.
Time of Update: 2021-03-22
041); (2) In the COUGH-2 study, at the 24th week of treatment, compared with the placebo group, the 24-hour cough frequency of the 45 mg dose of gefapixant twice a day was significantly reduced by 14.
-
Large hospitals have entered the era of one hospital with multiple districts!
Time of Update: 2021-03-22
The recent meeting of the Central Deep Reform Commission made it clear that it is necessary to accelerate the expansion of high-quality medical resources and the balanced distribution of regions, which is considered to be the fundamental guideline for the development of multiple districts in one hospital.
-
How can biopharmaceons innovate and purchase more for the good of the country and the people in the new era?
Time of Update: 2021-03-22
Innovative procurement policies need to pay attention to the particularity of biological products, and fully consider the "three characteristics" of specific products (similarity of biosimilars, stability of production and supply, and clinical substitutability) to formulate appropriate policies to ensure the safety of patients' medications and promote The healthy development of the industry.
-
Our country's fight against poverty has won an all-round victory!
Time of Update: 2021-03-22
As of the end of 2020, the medical insurance and poverty alleviation policies have benefited 530 million people from the poor, reducing the burden of medical expenses of the poor by more than 360 billion yuan (2020 National Basic Medical Insurance Fund for the current period) The balance is about 270 billion yuan).
-
The top 5 best-selling gout drugs in pharmacies exposed to the first "siege"
Time of Update: 2021-03-22
Sales of terminal anti-gout preparations in physical pharmacies in cities in China Source: Mi Nei. com, China's urban physical pharmacy terminal competition pattern In recent years, the market scale of terminal anti-gout preparations in Chinese urban physical pharmacies has been expanding, and the annual growth rate has remained at double digits.
-
Special purchase with quantity is coming
Time of Update: 2021-03-22
cn/news/yyzb/" target="_blank"> Procurement Procurement Centralized procurement and renewal time summary (Drawing: Fengyun Medicine Talk) Although the fifth batch of national centralized procurement and special volume procurement in 2021 are the focus of the industry, for pharmaceutical companies, the renewal of centralized procurement is also a top priority.
-
Over 400 pharmacies cancelled and delisted
Time of Update: 2021-03-22
Since the second half of last year, Shandong, Henan, Guangdong, Sichuan, Chongqing, Shaanxi, Yunnan and other places have issued announcements on the cancellation of the "Drug Business License", and a large number of pharmacies have withdrawn from the market.
-
2020 Health Care Development Statistics Express
Time of Update: 2021-03-22
8%。 （） The total income and total expenditures of the basic medical insurance fund (including maternity insurance) for the year were 2.
The income from the basic medical insurance fund (including maternity insurance) for employees in the whole year was 1,562.
-
New target IL-36R, a new drug for psoriasis, a phase II study failed
Time of Update: 2021-03-22
On March 8, AnaptysBio announced that the top-line data of the phase II clinical study (POPLAR) of the anti-IL-36R monoclonal antibody imsidolimab for the treatment of moderate to severe palmoplantar pustulosis (PPP) did not meet the primary endpoint.
-
China Biopharmaceuticals won the ANDA!
Time of Update: 2021-03-22
At present, there are three domestic manufacturers of fosapitan and dimeglumine for injection: Jiangsu Haosen Pharmaceutical, Zhengda Tianqing Pharmaceutical Group, and Qilu Pharmaceutical.
-
Xinhua Pharmaceutical Lactic Acid Bacteria Granules Obtained Drug Registration Certificate from NMPA
Time of Update: 2021-03-22
Lactic acid bacteria granules are over-the-counter drugs.
Lactobacillus is a class of peptides, proteins or protein complexes with antibacterial activity produced by lactic acid bacteria through ribosome synthesis mechanism in the metabolic process after skimmed milk is fermented.
-
Two Sessions Topics | Ke Yunfeng's voice affects 520,000 pharmacies
Time of Update: 2021-03-22
Attachment: Suggestions on the revision of the "Anti-Unfair Competition Law"The country has been encouraging the development of the Internet and platform economy for many years.
The revision of the "Anti-Unfair Competition Law" is conducive to establishing a correct understanding of the real economy and platform economy and the need for top-level design.
-
An imported anti-inflammatory drug Otezla submits an application in the United States for the treatment of mild to moderate plaque psoriasis
Time of Update: 2021-03-22
ADVANCE (PSOR-022) is a multicenter, randomized, placebo-controlled, double-blind phase 3 study that evaluates the efficacy and safety of Otezla in the treatment of mild to moderate plaque psoriasis.
-
Government Work Report: Health Care Reform, Collection, Antitrust...
Time of Update: 2021-03-22
39 35，，，，“”“”。，，，，，，，，、，。 2020 ：。，“”，“”，，、。，，“”，。，，。，，2. 6，1. 7。，2，，。，，50%，1. 5。“”。，，，2. 3%，，。 ，。，。，。，。1186，5. 2%。，，。，2. 5%。、、。。，、600，800。 ，。。，。，，。，。。551、52。 ，。。“”，。。。。、。“”。。。，。 ，。，。。，，。，。 ，。。
-
[Attention] The third domestic product!
Time of Update: 2021-03-22
Recently, Kelun Pharmaceutical entered the administrative examination and approval stage with the imitation of sunitinib malate capsules for production of category 4, and it is expected to be approved in the near future, sprinting into the third domestic market.
-
Successful Phase II proof-of-concept study of GlaxoSmithKline's first in class AIDS drug
Time of Update: 2021-03-22
The Phase IIa study adopted an adaptive design and included two phases to evaluate the antiviral activity, safety, and tolerability of GSK3640254 once a day in 34 untreated adult HIV-1 infected patients.
-
In 2021, 69 UDI categories in 9 categories will be promoted globally
Time of Update: 2021-03-22
69 varieties in 9 categories have landed In the field of production, the Food and Drug Administration of Fujian Province pointed out that the country’s first batch of 69 varieties of 9 categories of unique medical device identification has been officially implemented.
-
Insulin or take the lead in centralized procurement market pattern or face remodeling
Time of Update: 2021-03-22
Some analysts pointed out that with the advancement of centralized insulin procurement, domestic companies are expected to rely on price advantages to realize import substitution, achieve national market access, and gain a larger market share, thereby realizing a reshuffle of the industry's competitive landscape.
-
Shanxi: Novartis and other three companies adjusted the reference price of online drug purchases
Time of Update: 2021-03-22
On March 10, 2021, the Shanxi Provincial Pharmaceutical Equipment Centralized Bidding Procurement Center issued the "Notice on Adjusting the Reference Price of Online Drug Purchases by Beijing Novartis Pharmaceutical Co.
The purchase reference price of valsartan capsules (trade name: Divin) produced by Beijing Novartis Pharmaceutical Co.
-
Research on Collaborative Innovation Development of Biomedicine Industry in Guangdong-Hong Kong-Macao Greater Bay Area
Time of Update: 2021-03-22
The Guangdong-Hong Kong-Macao Greater Bay Area is an important area where my country’s biomedical industry gathers. It has a complete industrial foundation and leading strength. With the developmen
